Top Real World Evidence Analytics Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Real World Evidence Analytics Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Real World Evidence Analytics industry players.

Real World Evidence Analytics Market Competitive Landscape

Global Real World Evidence Analytics Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Top Players in Real World Evidence Analytics Market

  • IQVIA Inc. (US) 
  • Optum, Inc. (US) 
  • IBM Corporation (US) 
  • Parexel International Corporation (US) 
  • Cognizant Technology Solutions Corporation (US) 
  • Oracle Corporation (US) 
  • Clinigen Group PLC (UK) 
  • SAS Institute Inc. (US) 
  • PPD, Inc. (US) 
  • Syneos Health, Inc. (US) 
  • Anthem, Inc. (US) 
  • Change Healthcare Inc. (US) 
  • Evidera, Inc. (US) 
  • ICON plc (Ireland) 
  • Flatiron Health, Inc. (US) 
  • HealthVerity, Inc. (US) 
  • Phesi Inc. (US) 
  • Aetion, Inc. (US) 
  • Medidata Solutions (US) 
  • Clarify Health Solutions (US)

Real World Evidence Analytics Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Real World Evidence Analytics Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.59 billion in 2024 to USD 4.84 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Global Real World Evidence Analytics Market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'IQVIA Inc. (US) ', 'Optum, Inc. (US) ', 'IBM Corporation (US) ', 'Parexel International Corporation (US) ', 'Cognizant Technology Solutions Corporation (US) ', 'Oracle Corporation (US) ', 'Clinigen Group PLC (UK) ', 'SAS Institute Inc. (US) ', 'PPD, Inc. (US) ', 'Syneos Health, Inc. (US) ', 'Anthem, Inc. (US) ', 'Change Healthcare Inc. (US) ', 'Evidera, Inc. (US) ', 'ICON plc (Ireland) ', 'Flatiron Health, Inc. (US) ', 'HealthVerity, Inc. (US) ', 'Phesi Inc. (US) ', 'Aetion, Inc. (US) ', 'Medidata Solutions (US) ', 'Clarify Health Solutions (US)'

Rising geriatric population (and the subsequent increase in the prevalence of chronic diseases) is a key factor driving the growth of the market. The shift from volume- to value-based care, delays in drug development (and the subsequent increase in development costs), growth in R&D spending, and support from regulatory bodies for the use of RWE solutions are some of the other major factors that are driving the growth of this market.

Introduction of AI to Surge Market Growth: Real-world data (RWD) uses artificial intelligence (AI) to improve data standards, quality control, and anomaly identification at the pre-processing stage. Al is anticipated to give pharmaceutical and biotechnology organisations the capacity to boost meaningful RWE output, shorten time to insights, and make the most of the numerous data sources at their disposal. An unrivalled chance to benefit from these computing improvements is provided by RWE technology platforms that give smart data processing, analysis, and outcomes. Al innovations can improve drug research, patient care & access, and valuable promote new business prospects when implemented as a part of a holistic RWE strategy.

North America dominated the market in 2021. Some of the key factors anticipated to propel the growth of this market include the rising prevalence of chronic diseases in the elderly population, a move toward value-based care, an increase in personalised healthcare, the availability of electronic datasets, a well-established healthcare industry, and the growth of big data in the healthcare sector.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Real World Evidence Solutions Market
Buy Now GET FREE SAMPLE
Document Analytics Market
Buy Now GET FREE SAMPLE
Data Analytics Market
Buy Now GET FREE SAMPLE
Risk Analytics Market
Buy Now GET FREE SAMPLE
CRM Analytics Market
Buy Now GET FREE SAMPLE
Social Media Analytics Market
Buy Now GET FREE SAMPLE
Predictive Analytics Market
Buy Now GET FREE SAMPLE
Advanced Analytics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Real World Evidence Analytics Market
Real World Evidence Analytics Market

Report ID: SQSG35G2031

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE